ArticleJMIR research protocols2026
Factors Influencing the Transition From Physiological Hyperopia to Myopia in Children: Protocol for a Prospective Nested Case-Control Study.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early onset of myopia in children has become a critical public health issue that requires urgent attention. Notably, high myopia-related retinal diseases have emerged as the leading cause of irreversible blindness in adults in certain regions of China. Physiological hyperopia, as a protective factor and one of the strongest predictors of myopia development, plays a key role in delaying the progression of early-onset myopia and reducing the risk of high myopia in adulthood. However, the dynamic changes, critical turning points, and factors contributing to the rapid regression of physiological hyperopia during childhood remain unclear. Objective: This study aims to explore the key influencing factors for children's physiological hyperopia fading and myopia onset, as well as the protective mechanisms of physiological hyperopia against myopia. Methods: This was a prospective nested case-control study. Our research team previously established a prospective cohort of 2109 preschool children, aged 3 to 6 years, through cluster sampling in 22 kindergartens in Haidian District, Beijing, and completed a 3-year follow-up. Building on this cohort, this study adopts a prospective nested case-control design. We will continue to follow up this cohort with a 3-year longitudinal study, tracking children aged 6 to 9 years. During the 3-year follow-up period, participants will undergo annual eye examinations and complete questionnaires regarding their living habits and environment. The primary outcome is incident myopia, while secondary outcomes include the prevalence of myopia and the changes in various ocular biological parameters. The study received ethics approval on April 7, 2024, from the Ethics Committee of Beijing Tongren Eye Center, Beijing Tongren Hospital (TREC2024-KY034) and was registered on July 5, 2024. Results: Participant recruitment began on July 10, 2024, and is expected to be completed by December 31, 2026. As of February 2026, recruitment is ongoing, and the final results are expected by December 2026. Conclusions: This prospective nested casecontrol study investigates the dynamic changes and regression patterns of physiological hyperopia in school-aged children and evaluates the associations between ocular biometric parameters and the onset of myopia. The findings are expected to support standardized myopia screening, inform clinical interventions, and provide evidence-based guidance for government policies on myopia prevention and control in young children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.